Thomas Flaten
Stock Analyst at Lake Street
(2.76)
# 2,027
Out of 5,006 analysts
30
Total ratings
37.5%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $42 → $70 | $42.16 | +66.03% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $7.29 | +78.33% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $3.69 | +116.80% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $6.93 | +102.02% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.19 | +265.30% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $60 → $40 | $7.54 | +430.50% | 1 | May 14, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $23.33 | +50.02% | 6 | May 6, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $5.97 | +34.00% | 2 | Mar 7, 2025 | |
| EVAX Evaxion | Maintains: Buy | $35 → $6 | $6.95 | -13.67% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $7.20 | +25.00% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.89 | +235.53% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $3.16 | +248.10% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $26.52 | -5.73% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.43 | +59,159.26% | 2 | Nov 17, 2022 |
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $42.16
Upside: +66.03%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $7.29
Upside: +78.33%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $3.69
Upside: +116.80%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $6.93
Upside: +102.02%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.19
Upside: +265.30%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $7.54
Upside: +430.50%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $23.33
Upside: +50.02%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $5.97
Upside: +34.00%
Evaxion
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $6.95
Upside: -13.67%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $7.20
Upside: +25.00%
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.89
Upside: +235.53%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $3.16
Upside: +248.10%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $26.52
Upside: -5.73%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.43
Upside: +59,159.26%